The dualLIF™ solution is introduced with the combination of the dualX and dualPortal endoscopic systems. IRVINE, CALIF. (PRWEB) DECEMBER 16, 2021 Amplify Surgical, Inc., is pleased to announce the FIRST Endoscopic Transforaminal Lumbar...
3-month follow-up result65% pain reduction (ODI & VAS scales)Global launch in early January 2022510k expected in 2022 Eragny-sur-Oise, France, December 20th, 2021 17h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the...
Katherine Cunningham joined Ortho Consulting Group at the end of 2019 as General Counsel and leads the team responsible for all legal matters relating to company and client projects. Katherine qualified...
OVERLAND PARK, KAN. (PRWEB) DECEMBER 17, 2021 Spinal Simplicity, a medical device company, today announced the much-anticipated FDA clearance of a new Indication for Use (IFU) for its Minuteman family of implants, Lumbar Spinal...
Agreement follows initial utilisation of INVOcell by Ovoclinic phyisicians in early 2021, resulting in successful patient experiences and outcomes Ovoclinic will expand use of INVOcell in all four of their clinics...
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official distribution...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Camber Spine, a leading innovator in spine and medical technologies, has named Edward J. Vresilovic, Jr., M.D., Ph.D. as its new Chief Medical Officer. A leading board-certified...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board...
VANCOUVER, BC, Dec. 14, 2021 /PRNewswire/ - PrecisionOS® has expanded its Clinical Advisory Board with the addition of six prominent orthopedic surgeons specializing in shoulder and elbow surgery and research. The new members...
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) announced today that it has received a supplemental approval order from the U.S. Food and Drug Administration ("FDA") for the Patient Specific Talus Spacer....